Clinical Trials Directory

Trials / Unknown

UnknownNCT04456660

Comprehensive Assessment of Risks for Miscarriage.

Markers of Ultrasound, Immunologic & Serum Factors in the Comprehensive Analysis of Risks for Early Pregnancy Loss.

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Orthogyn Medical Center, Bulgaria · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study aims to determine the role of serum biomarkers and placental bloodflow in the comprehensive evaluation of the risk for spontaneous abortion

Detailed description

To study the added value (if any) of combining serum markers, immunologic factors, and ultrasound parameters in comprehensively evaluating the risk for spontaneous abortion.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMarkers of ultrasoundCRL, HR, and other ultrasound measurements.
DIAGNOSTIC_TESTImmunologic factorsMeasurement of NK cells subpopulations types in the maternal serum
DIAGNOSTIC_TESTSerum factorsMeasuring the maternal serum concentration of sFlt-1, PLGF, glycodelin-A, and other substances.

Timeline

Start date
2020-06-20
Primary completion
2023-11-20
Completion
2023-12-01
First posted
2020-07-02
Last updated
2023-10-26

Locations

1 site across 1 country: Bulgaria

Source: ClinicalTrials.gov record NCT04456660. Inclusion in this directory is not an endorsement.